Inventor · disambiguated record
Joel Renick
Also filed as: RENICK JOEL
13 granted patents·22 pending applications·567 citations·filing 1998–2015
93Inventor score
Files withTARGEGEN INC7BAYER AG5RIEDL BERND5BAYER PHARMACEUTICALS CORP2DART NEUROSCIENCE CAYMAN LTD2
Top patents by PatentIndex Score
35 records- 0197US7528143B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Granted May 5, 2009·220 cites·44 claims
- 0297US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0396US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0495US7825246B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2007·Granted Nov 2, 2010·40 cites·9 claims
- 0592US8604042B2Bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2010·Granted Dec 10, 2013·29 cites·5 claims
- 0688US6344476B1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 1998·Granted Feb 5, 2002·82 cites·18 claims
- 0785US8030487B22-amino—5-substituted pyrimidine inhibitorsTARGEGEN INC·Filed 2007·Granted Oct 4, 2011·10 cites·34 claims
- 0885US7456176B2Benzotriazine inhibitors of kinasesTARGEGEN INC·Filed 2005·Granted Nov 25, 2008·11 cites·34 claims
- 0984US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 1077US9708334B2Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jul 18, 2017·2 cites·20 claims
- 1165US2008032979A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 1263US2008153823A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 1361US2009118268A1OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORSRIEDL BERND·Filed 2008·Application pending·0 cites
- 1460US2010160371A1Inhibition of p38 kinase activity by aryl ureasRANGES GERALD·Filed 2009·Application pending·0 cites
- 1559US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1657US2001027202A1Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 1756US2007161645A1Thiazole inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 1854US2009275569A1Benzotriazine Inhibitors of KinasesGONG XIANCHANG·Filed 2008·Application pending·0 cites
- 1953US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 2053US2008108672A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2151US2007149508A1Six membered heteroaromatic inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 2250US2001016659A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 2350US2003105091A1Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 2450US2001034447A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 2549US2001011135A1Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 2649US2001011136A1omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 2748US2002137774A1Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 2847US2003144278A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2002·Application pending·0 cites
- 2946US2002103253A1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 2001·Application pending·0 cites
- 3045US2012040986A1Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2011·Application pending·0 cites
- 3143US8481536B2Benzotriazine inhibitors of kinasesGONG XIANCHANG·Filed 2010·Granted Jul 9, 2013·0 cites·5 claims
- 3241US2006247250A1Pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Application pending·0 cites
- 3339US2003207872A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2002·Application pending·0 cites
- 3436US10040759B2Substituted azetidinyl compounds as GlyT1 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Aug 7, 2018·0 cites·20 claims
- 3535US9012470B2Therapeutic 5,6,5-tricyclic analogsGUPTA VARSHA·Filed 2011·Granted Apr 21, 2015·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →